Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.69
At close: Jun 13 EDT
$6.70
0.010000.15%
Pre-Market: 4:00 AM EDT
Comments
Loading...
Day One Biopharmaceutical Stock Price, Quotes and Forecasts
DAWNNASDAQ
Day One Biopharmaceutical (DAWN) Forecast
NewsEarningsDay One Biopharmaceutical (DAWN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Day One Biopharmaceutical Stock Price, Quotes and Forecasts | NASDAQ:DAWN | Benzinga
Explore Day One Biopharmaceutical stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DAWN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Day One Biopharmaceutical (DAWN) stock?
You can purchase shares of Day One Biopharmaceutical (NASDAQ:DAWN) through any online brokerage.
Who are Day One Biopharmaceutical (DAWN) competitors?
Other companies in Day One Biopharmaceutical’s space includes: KalVista Pharma (NASDAQ:KALV), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Upstream Bio (NASDAQ:UPB) and Replimune Group (NASDAQ:REPL).
What is the forecast, or price target, for Day One Biopharmaceutical (DAWN) stock?
Day One Biopharmaceutical has a consensus price target of $32.78.
What is the current price for Day One Biopharmaceutical (DAWN)?
The stock price for Day One Biopharmaceutical (NASDAQ: DAWN) is $6.7 last updated June 13, 2025 at 4:00 AM EDT.
Does Day One Biopharmaceutical (DAWN) pay a dividend?
There are no upcoming dividends for Day One Biopharmaceutical.
When is Day One Biopharmaceutical (NASDAQ:DAWN) reporting earnings?
Day One Biopharmaceutical’s Q2 earnings are confirmed for Tuesday, July 29, 2025.
Is Day One Biopharmaceutical (DAWN) going to split?
There is no upcoming split for Day One Biopharmaceutical.
What sector and industry does Day One Biopharmaceutical (DAWN) operate in?
Day One Biopharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
